ArticleLancet (London, England)2021
Guidelines should not pool evidence from uncomplicated and severe COVID-19.
Article in Lancet (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.PLoS medicine · 2024Trial
- Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).The Journal of infectious diseases · 2023Trial
- Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry.European journal of internal medicine · 2022Trial
- Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match.BMJ global health · 2024Article
- The regrettable story of the "Covid Kit" and the "Early Treatment of Covid-19" in Brazil.Lancet regional health. Americas · 2021Review
- Contemporary narrative review of treatment options for COVID-19.Respirology (Carlton, Vic.) · 2021Review
- WHO COVID-19 therapeutic guidelines.Lancet (London, England) · 2021Article
- WHO COVID-19 therapeutic guidelines - Authors' reply.Lancet (London, England) · 2021Article
- COVID-19 chemoprevention.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021Article
- The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.Wellcome open research · 2021Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.